BDBM50070010 4-((2R,3R)-1-Benzylcarbamoyl-3-methyl-4-oxo-azetidin-2-yloxy)-benzoic acid::CHEMBL122575
SMILES C[C@@H]1[C@@H](Oc2ccc(cc2)C(O)=O)N(C(=O)NCc2ccccc2)C1=O
InChI Key InChIKey=BRYGRWNTDBRNDJ-YVEFUNNKSA-N
Data 3 IC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 3 hits for monomerid = 50070010
TargetChymotrypsinogen A(Bos taurus (bovine))
Glaxo Wellcome Research And Development
Curated by ChEMBL
Glaxo Wellcome Research And Development
Curated by ChEMBL
Affinity DataIC50: 1.60E+3nMAssay Description:Concentration of the compound required to inhibit the mammalian Chymotrypsinogen by 50% was determinedMore data for this Ligand-Target Pair
TargetCapsid scaffolding protein(Human cytomegalovirus (strain AD169) (HHV-5) (Huma...)
Glaxo Wellcome Research And Development
Curated by ChEMBL
Glaxo Wellcome Research And Development
Curated by ChEMBL
Affinity DataIC50: 2.00E+4nMAssay Description:Concentration of the compound required to inhibit the mutant alpha-Ala HCMV protease by 50% was determinedMore data for this Ligand-Target Pair
TargetAcetylcholinesterase(Homo sapiens (Human))
Glaxo Wellcome Research And Development
Curated by ChEMBL
Glaxo Wellcome Research And Development
Curated by ChEMBL
Affinity DataIC50: >1.00E+5nMAssay Description:Concentration of the compound required to inhibit the mammalian Acetylcholinesterase by 50% was determinedMore data for this Ligand-Target Pair